China NMPA Product Recall - Progesterone Assay Kit (Chemiluminescence Method) IMMULITE/IMMULITE 1000 Progesterone; Progesterone Assay Kit

On July 17, 2019, Siemens Medical Diagnostics Products (Shanghai) Co., Ltd. initiated a voluntary Class III recall for its Progesterone Assay Kits (Chemiluminescence Method). This action, reported by the Shanghai Food and Drug Administration under the oversight of the National Medical Products Administration (NMPA), was prompted by critical observations. The main issue identified was inconsistent progesterone levels in certain patient samples when tested using affected batches of the diagnostic kit. Such variability directly compromises the accuracy and reliability of diagnostic results, which are vital for effective patient care and treatment decisions. The regulatory framework under which this recall occurred emphasizes the importance of maintaining high standards for medical devices. Although classified as a Class III recall, indicating that the product's use is not likely to cause serious adverse health consequences, the company's proactive measure highlights its commitment to product quality and patient safety. The required action involves a thorough review and removal of the identified problematic batches from distribution. Comprehensive details regarding the affected product models, their specifications, and precise batch numbers are available in the associated Medical Device Recall Event Report Form, guiding all stakeholders in effectively addressing this performance issue and ensuring the integrity of medical diagnostics.